Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Gao, Guangxun"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 75
Tytuł:
Risk factors for multiple myeloma: a hospital-based case-control study in Northwest China.
Autorzy:
Wang Q (AUTHOR)
Wang Y (AUTHOR)
Ji Z (AUTHOR)
Chen X (AUTHOR)
Pan Y (AUTHOR)
Gao G (AUTHOR)
Gu H (AUTHOR)
Yang Y (AUTHOR)
Choi BC (AUTHOR)
Yan Y (AUTHOR)
Wang, Qixia (AUTHOR)
Wang, Yiwei (AUTHOR)
Ji, Zhaohua (AUTHOR)
Chen, Xiequn (AUTHOR)
Pan, Yaozhu (AUTHOR)
Gao, Guangxun (AUTHOR)
Gu, Hongtao (AUTHOR)
Yang, Yang (AUTHOR)
Choi, Bernard C K (AUTHOR)
Yan, Yongping (AUTHOR)
Pokaż więcej
Źródło:
Cancer Epidemiology. Oct2012, Vol. 36 Issue 5, p439-444. 6p.
Czasopismo naukowe
Szczegóły
Tytuł:
Low dose dinaciclib enhances doxorubicin-induced senescence in myeloma RPMI8226 cells by transformation of the p21 and p16 pathways.
Autorzy:
Tang H; Department of Hematology, Xijing Hospital, Air Force Military Medical University, Xi'an, Shaanxi 710032, P.R. China.
Xu L; Department of Hematology, Xijing Hospital, Air Force Military Medical University, Xi'an, Shaanxi 710032, P.R. China.
Liang X; School of Basic Medicine, Air Force Military Medical University, Xi'an, Shaanxi 710032, P.R. China.
Gao G; Department of Hematology, Xijing Hospital, Air Force Military Medical University, Xi'an, Shaanxi 710032, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2018 Nov; Vol. 16 (5), pp. 6608-6614. Date of Electronic Publication: 2018 Sep 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pharmacological inhibition of EZH2 combined with DNA‑damaging agents interferes with the DNA damage response in MM cells.
Autorzy:
Xu L; Department of Hematology, People's Liberation Army Center of Hematologic Disorders, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China.
Tang H; Department of Hematology, People's Liberation Army Center of Hematologic Disorders, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China.
Wang K; Department of Gastroenterology, The 16th Hospital of the People's Liberation Army of China, Xinjiang 836599, P.R. China.
Zheng Y; Department of Hematology, People's Liberation Army Center of Hematologic Disorders, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China.
Feng J; Department of Hematology, People's Liberation Army Center of Hematologic Disorders, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China.
Dong H; Department of Hematology, People's Liberation Army Center of Hematologic Disorders, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China.
Jin Y; Department of Hematology, People's Liberation Army Center of Hematologic Disorders, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China.
Cao C; Department of Hematology, People's Liberation Army Center of Hematologic Disorders, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China.
Chen X; Department of Hematology, People's Liberation Army Center of Hematologic Disorders, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China.
Gao G; Department of Hematology, People's Liberation Army Center of Hematologic Disorders, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2019 May; Vol. 19 (5), pp. 4249-4255. Date of Electronic Publication: 2019 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents/*pharmacology
DNA Damage/*drug effects
Enhancer of Zeste Homolog 2 Protein/*antagonists & inhibitors
Apoptosis/drug effects ; Caspases/metabolism ; Cell Cycle/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Humans ; Multiple Myeloma/genetics ; Multiple Myeloma/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of Survival Between Autologous and Allogeneic Stem Cell Transplantation in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Meta-Analysis.
Autorzy:
Wang, Jianhong
Duan, Xiaohui
Yang, Lijie
Liu, Xiangxiang
Hao, Caixia
Dong, Hongjuan
Gu, Hongtao
Tang, Hailong
Dong, Baoxia
Zhang, Tao
Gao, Guangxun
Liang, Rong
Pokaż więcej
Temat:
STEM cell transplantation
NON-Hodgkin's lymphoma
B cells
DISEASE progression
OVERALL survival
Źródło:
Cell Transplantation; Jan-Dec2020, Vol. 29, p1-15, 15p
Czasopismo naukowe
Szczegóły
Tytuł:
Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies.
Autorzy:
Si, Jingwen (AUTHOR)
Shi, Xiangjun (AUTHOR)
Sun, Shuhao (AUTHOR)
Zou, Bin (AUTHOR)
Li, Yaopeng (AUTHOR)
An, Dongjie (AUTHOR)
Lin, Xingyu (AUTHOR)
Gao, Yan (AUTHOR)
Long, Fei (AUTHOR)
Pang, Bo (AUTHOR)
Liu, Xing (AUTHOR)
Liu, Tian (AUTHOR)
Chi, Wenna (AUTHOR)
Chen, Ligong (AUTHOR)
Dimitrov, Dimiter S. (AUTHOR)
Sun, Yan (AUTHOR)
Du, Xinru (AUTHOR)
Yin, Wen (AUTHOR)
Gao, Guangxun (AUTHOR)
Min, Junxia (AUTHOR)
Pokaż więcej
Źródło:
Cancer Cell. Oct2020, Vol. 38 Issue 4, p551-551. 1p.
Czasopismo naukowe
Szczegóły
Tytuł:
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
Autorzy:
Mei H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.
Liu X; Thrombosis and Hemostasis Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin Laboratory of Blood Disease Gene Therapy, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China.
Li Y; Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Zhou H; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Feng Y; Department of Hematopathology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Gao G; The Blood Internal Medicine, The First Affiliated Hospital of Air Force Medical University, Xi'an, China.
Cheng P; Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Huang R; Hematology Department, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yang L; Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Hu J; Fujian Medical University Union Hospital, Fuzhou, China.
Hou M; Department of Hematology, Qilu Hospital, Shandong University, Jinan, China.
Yao Y; Hematology Department, Baoji Central Hospital, Baoji, China.
Liu L; Department of Hematopathology, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Wang Y; Department of Hematopathology, Shaanxi Provincial People's Hospital, Xi'an, China.
Wu D; Hematology Department, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhang L; Hematology Department, Lanzhou University Second Hospital, Lanzhou, China.
Zheng C; Hematology Department, The First Affiliated Hospital of USTC, Hefei, China.
Shen X; Department of Hematology, Heping Hospital Affiliated To Changzhi Medical College, Changzhi, China.
Hu Q; Department of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, China.
Liu J; The Third Xiangya Hospital of Central South University, Changsha, China.
Jin J; Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China.
Luo J; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Zeng Y; Department of Hematology, First Affiliated Hospital of Kunming Medical University, KunMing, China.
Gao S; The First Hospital of Jilin University, Changchun, China.
Zhang X; Department of Hematology, Peking University People's Hospital, Beijing, China.
Zhou X; Hematology Department, Wuxi People's Hospital, Wuxi, China.
Shi Q; Hematology Department, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Xia R; Hematology Department, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xie X; Hematology Department, The First People's Hospital of Changzhou, Changzhou, China.
Jiang Z; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Gao L; Department of Hematology, The Second Affiliated Hospital of Military Medical University PLA, Chongqing, China.
Bai Y; Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, China.
Li Y; Hematology Department, The First Hospital of China Medical University, Shenyang, China.
Xiong J; Clinical Research & Development, Jiangsu Hengrui Medicine Co., Ltd, Shanghai, China.
Li R; Clinical Research & Development, Jiangsu Hengrui Medicine Co., Ltd, Shanghai, China.
Zou J; Clinical Research & Development, Jiangsu Hengrui Medicine Co., Ltd, Shanghai, China.
Niu T; Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. dr_.
Yang R; Thrombosis and Hemostasis Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin Laboratory of Blood Disease Gene Therapy, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, 300020, China. .
Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2021 Feb 25; Vol. 14 (1), pp. 37. Date of Electronic Publication: 2021 Feb 25.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Hydrazones/*therapeutic use
Purpura, Thrombocytopenic, Idiopathic/*drug therapy
Pyrazolones/*therapeutic use
Receptors, Thrombopoietin/*agonists
Adult ; Double-Blind Method ; Female ; Humans ; Hydrazones/adverse effects ; Male ; Middle Aged ; Pyrazolones/adverse effects ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study
Autorzy:
Mei, Heng
Liu, Xiaofan
Li, Yan
Zhou, Hu
Feng, Ying
Gao, Guangxun
Cheng, Peng
Huang, Ruibin
Yang, Linhua
Hu, Jianda
Hou, Ming
Yao, Yazhou
Liu, Li
Wang, Yi
Wu, Depei
Zhang, Liansheng
Zheng, Changcheng
Shen, Xuliang
Hu, Qi
Liu, Jing
Jin, Jie
Luo, Jianmin
Zeng, Yun
Gao, Sujun
Zhang, Xiaohui
Zhou, Xin
Shi, Qingzhi
Xia, Ruixiang
Xie, Xiaobao
Jiang, Zhongxing
Gao, Li
Bai, Yuansong
Li, Yan
Xiong, Junye
Li, Runzi
Zou, Jianjun
Niu, Ting
Yang, Renchi
Hu, Yu
Pokaż więcej
Źródło:
Journal of Thrombosis and Haemostasis; March 2022, Vol. 20 Issue: 3 p716-728, 13p
Periodyk
Szczegóły
Tytuł:
Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities.
Autorzy:
Jia, Shuangshuang
Bi, Lei
Chu, Yuping
Liu, Xiao
Feng, Juan
Xu, Li
Zhang, Tao
Gu, Hongtao
Yang, Lan
Bai, Qingxian
Liang, Rong
Tian, Biao
Gao, Yaya
Tang, Hailong
Gao, Guangxun
Pokaż więcej
Temat:
MULTIPLE myeloma
PROGNOSTIC models
OVERALL survival
SURVIVAL analysis (Biometry)
REGRESSION analysis
Źródło:
Frontiers in Oncology; 3/17/2022, Vol. 12, p1-13, 13p
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 75

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies